Combat Drugs has received an approval for the full Disinvestment of the Fully Owned Subsidiary of the company in Singapore i.e. RA Labs by sale of entire Equity Shares held by the company, at cost, subject to shareholder approval and other statutory approvals, as applicable, if any. The Board of Directors of the company in their meeting approved the same.
Combat Drugs manufactures and markets pharmaceutical formulations in India. The company offers its products in various forms, such as tablets, capsules, liquid orals, and ointments.
